Cancer of the ovary - PubMed (original) (raw)

Review

. 2004 Dec 9;351(24):2519-29.

doi: 10.1056/NEJMra041842.

Affiliations

• PMID: 15590954
• DOI: 10.1056/NEJMra041842

Review

Cancer of the ovary

Stephen A Cannistra. N Engl J Med. 2004.

Erratum in

• N Engl J Med. 2005 Jan 6;352(1):104

No abstract available

PubMed Disclaimer

Comment in

• Cancer of the ovary.
  Matulonis U, Abrahm JL. Matulonis U, et al. N Engl J Med. 2005 Mar 24;352(12):1268-9; author reply 1268-9. doi: 10.1056/NEJM200503243521222. N Engl J Med. 2005. PMID: 15788509 No abstract available.
• Case 37-2004: postmenopausal bleeding and a cystic ovarian mass.
  Price FV. Price FV. N Engl J Med. 2005 Mar 24;352(12):1269-70; author reply 1269-70. doi: 10.1056/NEJM200503243521223. N Engl J Med. 2005. PMID: 15788510 No abstract available.
• Cancer of the ovary.
  Liu CM. Liu CM. N Engl J Med. 2005 Mar 24;352(12):1268-9; author reply 1268-9. N Engl J Med. 2005. PMID: 15791705 No abstract available.

Similar articles

• "BRCAness" syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations.
  Tan DS, Rothermundt C, Thomas K, Bancroft E, Eeles R, Shanley S, Ardern-Jones A, Norman A, Kaye SB, Gore ME. Tan DS, et al. J Clin Oncol. 2008 Dec 1;26(34):5530-6. doi: 10.1200/JCO.2008.16.1703. Epub 2008 Oct 27. J Clin Oncol. 2008. PMID: 18955455
• Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
  Rabban JT, Barnes M, Chen LM, Powell CB, Crawford B, Zaloudek CJ. Rabban JT, et al. Am J Surg Pathol. 2009 Aug;33(8):1125-36. doi: 10.1097/PAS.0b013e31819e986a. Am J Surg Pathol. 2009. PMID: 19440148
• Serum CA-125 in relation to adnexal dysplasia and cancer in women at hereditary high risk of ovarian cancer.
  Hermsen BB, von Mensdorff-Pouilly S, Berkhof J, van Diest PJ, Gille JJ, Menko FH, Blankenstein MA, Kenemans P, Verheijen RH. Hermsen BB, et al. J Clin Oncol. 2007 Apr 10;25(11):1383-9. doi: 10.1200/JCO.2006.06.7884. J Clin Oncol. 2007. PMID: 17416858
• PARP inhibition: targeting the Achilles' heel of DNA repair to treat germline and sporadic ovarian cancers.
  Carden CP, Yap TA, Kaye SB. Carden CP, et al. Curr Opin Oncol. 2010 Sep;22(5):473-80. doi: 10.1097/CCO.0b013e32833b5126. Curr Opin Oncol. 2010. PMID: 20485165 Review.
• BRCA1 and BRCA2 germ-line mutations and oral contraceptives: to use or not to use.
  Grenader T, Peretz T, Lifchitz M, Shavit L. Grenader T, et al. Breast. 2005 Aug;14(4):264-8. doi: 10.1016/j.breast.2005.01.005. Breast. 2005. PMID: 16085232 Review.

Cited by

• The cGAS-STING pathway and female reproductive system diseases.
  Li R, Liu H, Liu Y. Li R, et al. Front Immunol. 2024 Oct 9;15:1447719. doi: 10.3389/fimmu.2024.1447719. eCollection 2024. Front Immunol. 2024. PMID: 39445027 Free PMC article. Review.
• MIR937 amplification potentiates ovarian cancer progression by attenuating FBXO16 inhibition on ULK1-mediated autophagy.
  Zhang Z, Liu X, Chu C, Zhang Y, Li W, Yu X, Han Q, Sun H, Zhang Y, Zhu X, Chen L, Wei R, Fan N, Zhou M, Li X. Zhang Z, et al. Cell Death Dis. 2024 Oct 9;15(10):735. doi: 10.1038/s41419-024-07120-8. Cell Death Dis. 2024. PMID: 39384743 Free PMC article.
• Evaluating Ovarian Cancer Chemotherapy Response Using Gene Expression Data and Machine Learning.
  Amniouel S, Yalamanchili K, Sankararaman S, Jafri MS. Amniouel S, et al. BioMedInformatics. 2024 Jun;4(2):1396-1424. doi: 10.3390/biomedinformatics4020077. Epub 2024 May 22. BioMedInformatics. 2024. PMID: 39149564 Free PMC article.
• Organ-on-a-chip: future of female reproductive pathophysiological models.
  Deng ZM, Dai FF, Wang RQ, Deng HB, Yin TL, Cheng YX, Chen GT. Deng ZM, et al. J Nanobiotechnology. 2024 Jul 31;22(1):455. doi: 10.1186/s12951-024-02651-w. J Nanobiotechnology. 2024. PMID: 39085921 Free PMC article. Review.
• Histopathology and proteomics are synergistic for High-Grade Serous Ovarian Cancer platinum response prediction.
  Kilim O, Olar A, Biricz A, Madaras L, Pollner P, Szállási Z, Sztupinszki Z, Csabai I. Kilim O, et al. medRxiv [Preprint]. 2024 Jun 3:2024.06.01.24308293. doi: 10.1101/2024.06.01.24308293. medRxiv. 2024. PMID: 38883738 Free PMC article. Preprint.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information